RWD136 Real-World Use of Biologic Disease-Modifying Anti-Rheumatic Drugs in US Patients with Ankylosing Spondylitis: Persistence, Factors Associated with Discontinuation, and Dosing Patterns.

Value in Health

M. Dubreuil, J.A Walsh, A. Deodhar, L.S Gensler, J.R Curtis, S. Anjohrin, O. Pilipczuk, M. Feudjo Tepie, S. Beaty, M. Mørup, V. Taieb, S. Welby. RWD136 Real-World Use of Biologic Disease-Modifying Anti-Rheumatic Drugs in US Patients with Ankylosing Spondylitis: Persistence, Factors Associated with Discontinuation, and Dosing Patterns. Value in Health. 2023 Jun 1; 26(6):s386-s387.

2023

https://researcherprofiles.org/profile/425025944

M. Dubreuil, J.A Walsh, A. Deodhar, L.S Gensler, J.R Curtis, S. Anjohrin, O. Pilipczuk, M. Feudjo Tepie, S. Beaty, M. Mørup, V. Taieb, S. Welby

Search form

You are here

RWD136 Real-World Use of Biologic Disease-Modifying Anti-Rheumatic Drugs in US Patients with Ankylosing Spondylitis: Persistence, Factors Associated with Discontinuation, and Dosing Patterns.